<!DOCTYPE html><html><head><title> Pacifica Code Section 58-37-S5.5 </title><link rel="stylesheet" href="../../assets/style.css"/></head><body>
<b>58-37-5.5.&nbsp;
          </b><b>Recognized controlled substance analogs.</b>
<br>
<a id="58-37-5.5(1)" name="58-37-5.5(1)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(1)</td><td style="width:99%">
A substance listed under Subsection <a href="#58-37-5.5(2)">(2)</a> is an analog, as defined in Subsection <a href="../../Title58/Chapter37/58-37-S2.html?v=C58-37-S2_2015051220150512#58-37-2(1)(g)">58-37-2(1)(g)</a>, if the substance, in any quantity, and in any material, compound, mixture, or preparation, is present in:
<a id="58-37-5.5(1)(a)" name="58-37-5.5(1)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
any product manufactured, distributed, or possessed for the purpose of human consumption; or</td>
</tr>
</tbody></table>
<a id="58-37-5.5(1)(b)" name="58-37-5.5(1)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
any product, the use or administration of which results in human consumption.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-37-5.5(2)" name="58-37-5.5(2)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(2)</td><td style="width:99%">
Substances referred to in Subsection <a href="#58-37-5.5(1)">(1)</a> include, but are not limited to:
<a id="58-37-5.5(2)(a)" name="58-37-5.5(2)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
gamma butyrolactone (GBL);</td>
</tr>
</tbody></table>
<a id="58-37-5.5(2)(b)" name="58-37-5.5(2)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
butyrolactone;</td>
</tr>
</tbody></table>
<a id="58-37-5.5(2)(c)" name="58-37-5.5(2)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
1,2 butanolide;</td>
</tr>
</tbody></table>
<a id="58-37-5.5(2)(d)" name="58-37-5.5(2)(d)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(d)</td><td style="width:99%">
2-oxanolone;</td>
</tr>
</tbody></table>
<a id="58-37-5.5(2)(e)" name="58-37-5.5(2)(e)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(e)</td><td style="width:99%">
tetrahydro-2-furanone;</td>
</tr>
</tbody></table>
<a id="58-37-5.5(2)(f)" name="58-37-5.5(2)(f)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(f)</td><td style="width:99%">
dihydro-2 (3H)-furanone;</td>
</tr>
</tbody></table>
<a id="58-37-5.5(2)(g)" name="58-37-5.5(2)(g)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(g)</td><td style="width:99%">
tetramethylene glycol;</td>
</tr>
</tbody></table>
<a id="58-37-5.5(2)(h)" name="58-37-5.5(2)(h)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(h)</td><td style="width:99%">
1,4 butanediol; and</td>
</tr>
</tbody></table>
<a id="58-37-5.5(2)(i)" name="58-37-5.5(2)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
gamma valerolactone.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<br>
<br>Amended by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=250&amp;sess=2008GS">250</a>, 2008 General Session<br>
</body></html>